Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer

Canadian Journal of Surgery

Volumn 52, Issue 1, 2009, Pages 23-30

  Ramjeesingh, Ravi ^a   Quan, May Lynn ^a   Gardner, Sandra ^a   Holloway, Claire M B ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 62249100704     PISSN: 0008428X     EISSN: 14882310     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Recht A, Come SE, Gelman RS, et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol 1991;9:1662-7.
2. Chung MA, Steinhoff MM, Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 2002;184:310-4.
3. Porter GA, McMulkin H, Lovrics GA. Sentinel lymph node biopsy in breast cancer: Canadian practice patterns. Ann Surg Oncol 2003; 10:255-260.
4. Barone JE, Tucker JB, Perez JM, et al. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Am Surg 2005;71:66-70.
5. Veronesi U. The sentinel node and breast cancer. Br J Surg 1999; 86:1-2.
6. Kennedy RJ, Kollias J, Gill PG, et al. Removal of two sentinel nodes accurately stages the axilla in breast cancer. Br J Surg 2003; 90:1349-53.
7. Palesty JA, Foster JM, Hurd TC, et al. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. J Surg Oncol 2006;93:129-32.
8. de Kanter AY, Menke-Pluymers MM, Wouters MW, et al. 5-Year follow-up of sentinel node negative breast cancer patients. Eur J Surg Oncol 2006;32:282-6.
9. Khakpour N, Hunt KK, Kuerer HM, et al. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node. Am J Surg 2005;190:598-601.
10. Swenson KK, Mahipal A, Nissen MJ, et al. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma. Cancer 2 005; 104:183 4-9.
11. Zavagno G, Carcoforo P, Franchini Z, et al. Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. Eur J Surg Oncol 2005; 31:715-7.
12. Snider HC Jr, Rubin E, Henson R. Axillary ultrasonography to detect recurrence after sentinel node biopsy in breast cancer. Ann Surg Oncol 2006;13:501-7.
13. Julian TB, Krag D, Brown A, et al. Preliminary technical results of NSABP B-32, a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients. Breast Cancer Res Treat 2004;88:S11-2.
14. Cantin J, Scarth H, Levine M. Hugi M and the Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy. CMAJ 2001;165:166-73.
15. Voordeckers M, Vinh-Hung V, Van de Steene J, et al. The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 2004;70:225-30.
16. Gemignani ML., Borgen PI. Is there a role for selective axillary dissection in breast cancer? World J Surg 2001;25:809-18.
17. Nori J, Vanzi E, Bazzocchi M, et al. Role of axillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy. Am J Surg 2007;193:16-20.
18. Calhoun KE, Hansen NM, Turner RR, et al. Nonsentinel node metastases in breast cancer patients with isolated tumour cells in the sentinel node: implications for completion axillary dissection. Am J Surg 2005;190:588-91.
19. Chu KU, Turner RR, Hansen NM, et al. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohisto-chemically detectable nonsentinel lymph node metastasis. Ann Surg Oncol 1999;6:756-61.
20. Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003;29:341-50.
21. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer 1998;83:2776-81.
22. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003;10:1140-51.
23. Specht MC, Kattan MW, Gonen M, et al. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 2005;12:654-9.
24. Smidt ML, Kuster DM, van der Wilt GJ, et al. Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in the Netherlands? Ann Surg Oncol 2005;12:1066-72.
25. Soni NK, Carmalt HL, Gillett DJ, et al. Evaluation of a breast cancer nomogram for prediction of non-sentinel lymph node positivity. Eur J Surg Oncol 2005; 31:958-64.
26. Lambert LA, Ayers GD, Hwang RF, et al. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 2006;13:310-20.
27. Degnim AC, Reynolds C, Pantvaidya G, et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 2005;190:543-50.
28. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
29. Hosmer D, Lemeshow S. Assessing the fit of the model. In: Applied logistic regression. 1st ed. Hoboken (NJ): John Wiley & Sons; 1989. p. 140-5.
30. Rivers AK, Griffith KA, Hunt KK, et al. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol 2006;13:36-44.
31. Andea AA, Bouwman D, Wallis T, et al. Correlation of tumour volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 2004;100:20-7.
32. Yen TW, Hunt KK, Ross MI, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005;200:516-26.
33. Wada N, Imoto S, Yamauchi C, et al. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. Eur J Surg Oncol 2006;32:29-33.
34. Ozmen V, Karanlik H, Cabioglu N, et al. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat 2006;95:1-6.
35. Van den Eynden GG, Van der Auwera I, Van Laere SJ, et al. Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study. Br J Cancer 2006;94:1643-9.
36. Sachdev U, Murphy K, Derzie A, et al. Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg 2002; 183:213-7.
37. van Rijk MC, Deurloo EE, Nieweg OE, et al. Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol 2006;13:31-5.
38. Nori J, Bazzocchi M, Boeri C, et al. Role of axillary lymph node ultrasound and large core biopsy in the preoperative assessment of patients selected for sentinel node biopsy. Radiol Med 2005;109:330-44.
39. Rutledge H, Davis J, Chiu R, et al. Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Mod Pathol 2005;18:762-8.
40. Hurkmans CW, Borger JH, Rutgers EJ, et al.; EORTC Breast Cancer Cooperative Group. Radiotherapy Cooperative Group. Quality assurance of axillary radiotherapy in the EORTC AMAROS trial 10981/22023: the dummy run. Radiother Oncol 2003;68:233-40.
41. Reynolds C, Mick R, Donohue JH, et al. Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999;17:1720-6.
42. Turner RR, Chu KU, Qi K, et al. Predictive factors for metastatic involvement of nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89:574-81.
43. Abdessalam S, Zervos EE, Prasad M, et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 2001;182:316-20.
44. Weiser MR, Montgomery LL, Tan LK, et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001;8:145-9.
45. Viale G, Maiorano E, Masszrol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001;92:1378-84.
46. Kocsis L, Svebis M, Boross G, et al. Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am Surg 2004;70:1019-24.
47. Chao C, Abell T, Martin RC II, et al. Intraoperative frozen section of sentinel nodes: a formal decision analysis. Am Surg 2004;70:215-20